- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07330427
Impacto da Educação para a Saúde nos Conhecimentos, Atitudes e Práticas da Profilaxia Pós-Exposição
Impacto da Educação para a Saúde nos Conhecimentos, Atitudes e Práticas da Profilaxia Pós-Exposição entre Profissionais de Saúde no Hospital Universitário de Aswan, Egito
The goal of this study is to learn whether a short education programme helps healthcare workers know more about post-exposure prophylaxis (PEP). PEP is medicine taken soon after contact with blood or body fluids, to lower the chance of infection. The study takes place at Aswan University Hospital in Egypt.
The main questions it aims to answer are:
Do healthcare workers know more about PEP three months after the programme than before it?
Do their attitudes toward PEP change?
Do their reported actions change, such as hepatitis B vaccination, use of PEP after an exposure, and finishing the prescribed course?
Participants are doctors, nurses, and laboratory and blood bank staff who work with patients or blood samples. They will:
Fill out a questionnaire before the programme.
Attend four 2-hour teaching sessions over two weeks.
Fill out the same questionnaire about three months later.
All participants receive the programme. There is no comparison group. Researchers will compare each person's answers before and after the programme to see what changed.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Design. This is a single-group, before-and-after (quasi-experimental) study. Each participant completes a baseline questionnaire before teaching and a follow-up questionnaire about three months after their group finishes teaching. Coded identifiers link the two questionnaires. The study ran from 30 January 2026 to 30 June 2026.
Setting and participants. The study took place at Aswan University Hospital in southern Upper Egypt. Staff were selected by stratified random sampling from three groups: physicians and clinically active academic staff, nurses, and laboratory and blood bank staff. Workers had to be actively employed in one of these groups, have worked at the hospital for at least six months, and give written informed consent. Non-clinical, housekeeping and auxiliary staff were excluded. In total, 380 workers were selected, and the target was 340 with complete before-and-after data.
Intervention. The programme had four 2-hour sessions over two weeks. Topics were:
Recognising and reporting an exposure.
First aid.
Assessing the source patient and the exposure.
Access to PEP in the hospital.
Hepatitis B vaccination.
HIV PEP timing and duration.
Adherence, counselling and follow-up testing.
The programme also covered the difference between HIV prophylaxis, hepatitis B prevention and hepatitis C follow-up. Teaching used slides, short videos, case scenarios, group discussion and printed materials. Physicians were taught in English, and nurses and laboratory staff in Arabic.
Measures. A questionnaire, adapted from published PEP surveys and available in Arabic and English, was used at both time points.
Primary outcome: change in a five-item knowledge score (0-5), calculated as follow-up score minus baseline score.
Secondary outcomes: change in a seven-item attitude and belief score (0-7), and individual practice indicators. These are self-reported hepatitis B vaccination, PEP use after exposure, time to starting PEP, and completion of the prescribed course.
Analysis. Paired changes are tested with the Wilcoxon signed-rank test for scores and the exact McNemar test for yes/no responses. Confidence intervals are reported for paired differences. The sample size was calculated to estimate a proportion with 5% precision, not to detect a difference between paired groups.
Changes from the original registration. The original record described nine knowledge questions and threshold-based classifications of knowledge, attitude and practice. The final analysis uses a five-item knowledge score, a seven-item attitude total without an overall classification, and individual practice indicators. The dates were updated to the actual start (30 January 2026) and completion (30 June 2026).
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Aswān, Egito
- Aswan faculty of Medicine
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- HCWs at the selected departments (physicians, nurses and housekeepers).
- Age >18 years old and below 60 years old in both Genders.
- HCWs which have direct contact with blood and body fluids.
Exclusion Criteria:
- Age<18 years old and above 60 years old.
- Non-medical staff at Aswan university hospital.
- Health care workers which have no contact with blood or body fluids.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Health Care workers
About 340 participants of heath care workers undergoing assessment of knowledge, attitude and practice about post-exposure prophylaxis among health care workers at Aswan university hospital, Egypt Then they will undergo lecturers about about post-exposure prophylaxis, then reassessment will be done after 3 months |
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Health Practice Change
Prazo: 3 Months
|
Assessment of participants after taking health education lecturers about post-exposure prophylaxis regrading to knowledge, attitude and practice and this done by questionnaire as :The questionnaire consisted of three sections assessing knowledge, attitude, and practice regarding post-exposure prophylaxis (PEP). Section B assessed knowledge using nine close-ended questions, with adequate knowledge defined as ≥75% correct answers. Section C included seven items evaluating attitudes toward the importance and effectiveness of PEP, with scores ≥75% indicating a good attitude. Section D assessed PEP practices through nine questions, and good practice was defined as positive responses to more than 75% of items. |
3 Months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Shaimaa Sayed Abdelrheem, M.D, Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Infecções transmitidas pelo sangue
- Infecções
- Doenças Virais
- Doenças do aparelho digestivo
- Doenças do Fígado
- Hepatite, Viral, Humana
- Doenças Transmissíveis
- Infecções por vírus de DNA
- Infecções Hepadnaviridae
- Hepatite
- Comportamento
- Adesão e Cumprimento do Tratamento
- Comportamento de saúde
- Conformidade do paciente
- Aceitação dos Cuidados de Saúde pelo Paciente
- Intervenções de adesão
- Adesão à Medicação
- Hepatite B
- Educação saudável
Outros números de identificação do estudo
- Post-exposure prophylaxis
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .